First Level Socio-geriatric Evaluation: ESOGER Databank

First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank

Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER ("Evaluation Social et GERiatrique") is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.

Study Overview

• Status: Active, not recruiting
• Conditions: Anxiety; Frailty; COVID; Social Isolation
• Intervention / Treatment: Other: ESOGER

• Study Type: Observational
• Enrollment (Actual): 20000

Contacts and Locations

Study Locations

• Canada
  • Quebec
    • Montréal, Quebec, Canada, H3T 1E2
      • Jewish General Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 70 years and older (Older Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

All the older patients and community dwellers living at home in Montreal contacted by the researchers and corresponding to the criteria.

The project is about a constitution of a databank.

Description

The inclusion criteria are:

1. Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria
2. Living and staying at home because of physical and social distancing
3. Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.)
4. Agree to participate in the study

The exclusion criteria are:

1. A concomitant participation to another medical trial
2. Living in semi-autonomous residence or CHSLD

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Older patients / community dwellers; The inclusion criteria are: Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria; Living and staying at home because of physical and social distancing; Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.); Agree to participate in the study The exclusion criteria are: A concomitant participation to another medical trial; Living in semi-autonomous residence or CHSLD

Other: ESOGER; Questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
COVID-19 symptoms	presence or not of fever, cough and shortness of breath (binary question)	1 day
issues related to medication and food delivery and access to home care	presence or not of a rupture of access to food, medication and home care (binary question)	1 day
physical frailty	Questionnaire Emergency Room Evaluation and Recommandation (ER2), score from 0 = no risk of frailty to 14 = high risk of frailty)	1 day
psychological frailty	anxiety Verbal analogic scale, score from 0 = no anxiety to 10 = extremely anxious)	1 day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Caregiver burden	Zarit scale, score from 0 = no caregiver burden to 16 = high caregiver burden)	1 day

Collaborators and Investigators

• Sponsor: Jewish General Hospital

Study record dates

Study Major Dates

• Study Start (Actual): April 20, 2020
• Primary Completion (Estimated): April 19, 2027
• Study Completion (Estimated): April 19, 2027

Study Registration Dates

• First Submitted: May 13, 2020
• First Submitted That Met QC Criteria: May 13, 2020
• First Posted (Actual): May 19, 2020

Study Record Updates

• Last Update Posted (Actual): February 23, 2024
• Last Update Submitted That Met QC Criteria: February 22, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Frailty
• Other Study ID Numbers: MP-05-2021-2308

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No